APA (7th ed.) Citation

Su, S., Wang, Y., Wu, Y., Wang, D., Lin, Q., & Hai, J. (2016). Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling. Behavioural brain research, 313, 334-344. https://doi.org/10.1016/j.bbr.2016.07.009

Chicago Style (17th ed.) Citation

Su, Shao-Hua, Yue-Qing Wang, Yi-Fang Wu, Da-Peng Wang, Qi Lin, and Jian Hai. "Cannabinoid Receptor Agonist WIN55,212-2 and Fatty Acid Amide Hydrolase Inhibitor URB597 May Protect Against Cognitive Impairment in Rats of Chronic Cerebral Hypoperfusion via PI3K/AKT Signaling." Behavioural Brain Research 313 (2016): 334-344. https://doi.org/10.1016/j.bbr.2016.07.009.

MLA (9th ed.) Citation

Su, Shao-Hua, et al. "Cannabinoid Receptor Agonist WIN55,212-2 and Fatty Acid Amide Hydrolase Inhibitor URB597 May Protect Against Cognitive Impairment in Rats of Chronic Cerebral Hypoperfusion via PI3K/AKT Signaling." Behavioural Brain Research, vol. 313, 2016, pp. 334-344, https://doi.org/10.1016/j.bbr.2016.07.009.